Related references
Note: Only part of the references are listed.Emerging role of LETM1/GRP78 axis in lung cancer
Quangdon Tran et al.
CELL DEATH & DISEASE (2022)
Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER+ Breast Cancer
Alberto Servetto et al.
CLINICAL CANCER RESEARCH (2021)
PI3K inhibitors are finally coming of age
Bart Vanhaesebroeck et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA
Chenwei Li et al.
NUCLEIC ACIDS RESEARCH (2021)
Targeting PI3K Pathway in Pancreatic Ductal Adenocarcinoma: Rationale and Progress
Siddharth Mehra et al.
CANCERS (2021)
Mitochondria as multifaceted regulators of cell death
Florian J. Bock et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
Jia-qiao Fan et al.
MOLECULAR CANCER (2020)
Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1
Junrong Wang et al.
AGING-US (2020)
Development and validation of a novel nomogram for pretreatment prediction of liver metastasis in pancreatic cancer
Shangxiang Chen et al.
CANCER MEDICINE (2020)
Leucine Zipper-EF-Hand Containing Transmembrane Protein 1 Is a Potential Prognostic Biomarker and Promotes Cell Progression in Prostate Cancer
Lihua Piao et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Therapeutic Potential of PI3K/AKT/mTOR Pathway in Gastrointestinal Stromal Tumors: Rationale and Progress
Yi Duan et al.
CANCERS (2020)
LETM1 Promotes Gastric Cancer Cell Proliferation, Migration, and Invasion via the PI3K/Akt Signaling Pathway
Yunfeng Zhang et al.
JOURNAL OF GASTRIC CANCER (2020)
The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism
Gerta Hoxhaj et al.
NATURE REVIEWS CANCER (2020)
Early Detection of Pancreatic Cancer: Opportunities and Challenges
Aatur D. Singhi et al.
GASTROENTEROLOGY (2019)
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Jing Yang et al.
MOLECULAR CANCER (2019)
LETM1: Essential for Mitochondrial Biology and Cation Homeostasis?
Shane Austin et al.
TRENDS IN BIOCHEMICAL SCIENCES (2019)
PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside
Ali S. Alzahrani
SEMINARS IN CANCER BIOLOGY (2019)
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study
Melina Arnold et al.
LANCET ONCOLOGY (2019)
Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine
James R. W. Conway et al.
GUT (2019)
Molecular Mechanisms of Leucine Zipper EF-Hand Containing Transmembrane Protein-1 Function in Health and Disease
Qi-Tong Lin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Therapeutic developments in pancreatic cancer: current and future perspectives
John P. Neoptolemos et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer
Kaixuan Wang et al.
ONCOGENE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
The PI3K Pathway in Human Disease
David A. Fruman et al.
CELL (2017)
The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing
Teresa Helsten et al.
CLINICAL CANCER RESEARCH (2016)
Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma
Caixia Cheng et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer
Jonathan C. Irish et al.
MOLECULAR ONCOLOGY (2016)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Targeting the PI3K/Akt pathway in prostate cancer: Challenges and opportunities (Review)
Paul Toren et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
PPAPDC1B and WHSC1L1 Are Common Drivers of the 8p11-12 Amplicon, Not Only in Breast Tumors But Also in Pancreatic Adenocarcinomas and Lung Tumors
Sardar F. Mahmood et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Small molecule-induced cytosolic activation of protein kinase Akt rescues ischemia-elicited neuronal death
Hakryul Jo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis
Alyssa L. Kennedy et al.
MOLECULAR CELL (2011)
Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
Amit Dutt et al.
PLOS ONE (2011)
Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer
R. Tabares-Seisdedos et al.
MOLECULAR PSYCHIATRY (2009)
Epidemiology of pancreatic cancer: an overview
Sara Raimondi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2009)
Characterization of the mitochondrial protein LETM1, which maintains the mitochondrial tubular shapes and interacts with the AAA-ATPase BCS1L
Shoko Tamai et al.
JOURNAL OF CELL SCIENCE (2008)
The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer
Adrian J. Folkes et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocation
J. C. M. Pole et al.
ONCOGENE (2006)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
Incidence, mechanism and prognostic value of activated AKT in pancreas cancer
MG Schlieman et al.
BRITISH JOURNAL OF CANCER (2003)
The human genome browser at UCSC
WJ Kent et al.
GENOME RESEARCH (2002)
WHSC1L1, on human chromosome 8p11.2, closely resembles WMSC1 and maps to a duplicated region shared with 4p16.3
I Stec et al.
GENOMICS (2001)
Share Paper
